Kinetics of mouse jejunum radiosensitization by 2',2'-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells
1997

Effect of Gemcitabine on Mouse Jejunum Radiosensitization

Sample size: 6 publication Evidence: moderate

Author Information

Author(s): V Gregoire, M Beauduin, J-F Rosier, B De Coster, M Bruniaux, M Octave-Prignot, P Scalliet

Primary Institution: UCL St-Luc University Hospital

Hypothesis

The study aims to determine the effect of dFdC on mouse jejunum radiosensitization and investigate the kinetics of DNA synthesis inhibition and cell cycle redistribution.

Conclusion

Gemcitabine alters the radioresponse of the mouse jejunum in a schedule-dependent manner, with radiosensitization observed shortly after administration.

Supporting Evidence

  • Gemcitabine inhibited DNA synthesis within 3 hours after administration.
  • Radiosensitization was observed for a 3-hour time interval with a dose modification factor of 1.3.
  • A slight radioprotection was observed for a 48-hour time interval with a dose modification factor of 0.9.
  • DNA synthesis inhibition and cell cycle redistribution are suggested as surrogates for radiosensitization.

Takeaway

This study looks at how a drug called gemcitabine affects the ability of mouse intestines to handle radiation, showing that it can make the intestines more sensitive to radiation if given at the right time.

Methodology

Mice were irradiated with gamma rays and treated with gemcitabine to assess jejunum tolerance and DNA synthesis inhibition.

Limitations

More data points are required before a definite conclusion can be drawn.

Participant Demographics

Ten- to twelve-week-old male C3H mice were used.

Statistical Information

P-Value

p<0.05

Confidence Interval

13.09-14.84 Gy

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication